Hims & Hers Health, Inc. revised earnings guidance for the year 2022. For the full year, the company is raising revenue outlook to between $470 million and $485 million, which represents year-over-year growth of between 73% and 78%.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.28 USD | +0.37% | -3.10% | +36.10% |
Apr. 26 | Seaport Global Starts Hims & Hers Health With Buy Rating | MT |
Apr. 16 | Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.10% | 2.63B | |
-37.97% | 2.2B | |
+24.80% | 531M | |
+115.18% | 467M | |
-65.10% | 154M | |
-41.01% | 77.59M |
- Stock Market
- Equities
- HIMS Stock
- News Hims & Hers Health, Inc.
- Hims & Hers Health, Inc. Revises Earnings Guidance for the Year 2022